Institutional & Family Asset Management, LLC Fibrogen Inc Transaction History

Institutional & Family Asset Management, LLC

$846 Million
Q2 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$13.27 - $17.73 $318 - $425	24 New	24 $0
Q2 2019 Aug 14, 2019	SELL	$35.13 - $55.53 $1,089 - $1,721	-31 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$44.9 - $64.95 $449 - $649	10 Added 47.62%	31 $2,000
Q1 2018 May 14, 2018	BUY	$45.35 - $61.65 $952 - $1,294	21 New	21 $1,000

Others Institutions Holding FGEN

# of Institutions

Shares Held

46.8M

Call Options Held

387K

Put Options Held

672K

Primecap Management CO Pasadena, CA

9.91M
Shares

$4.96 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

6.8M
Shares

$3.4 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$2.94 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$1.95 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$1.2 Million
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $46.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Account